Bayer, Khloris Team Up to Develop Anti-Cancer Vaccines
April 02 2019 - 01:14PM
Dow Jones News
By Sarah Sloat
Bayer AG (BAYN.XE) said Tuesday its investment arm is teaming up
with biotechnology startup Khloris Biosciences to develop
anti-cancer vaccines to based on stem cells.
Bayer's investment--through its Leaps by Bayer unit--in the
project wasn't disclosed.
The cooperation will focus on a kind of stem cells that have
potential for anti-cancer vaccines because they share
characteristics with cancer cells, such as the ability to
self-renew, Bayer said.
"Bayer's development expertise, commercial reach and worldwide
network of R&D sites, combined with our scientific knowledge
and technology, will increase the chances to bring this potential
breakthrough option to patients in need," said Joseph C. Wu, a
cofounder of Khloris.
Write to Sarah Sloat at sarah.sloat@wsj.com
(END) Dow Jones Newswires
April 02, 2019 12:59 ET (16:59 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Mar 2023 to Mar 2024